Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces the appointment of Dr. Birge Berns, MD, as the Company’s interim Chief Medical Officer.
Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces the appointment of Dr. Birge Berns, MD, as the Company’s interim Chief Medical Officer.